BIOMAT Database Logo BIOMAT Database Logo

Double-blind study comparing the intramuscular usage of an acridan derivative, SK&F 14336, to chlorpromazine. 1970

C P Chien, and M Sah, and G C Dubiel, and L Lu

UI MeSH Term Description Entries
D011618 Psychotic Disorders Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994) Psychoses,Psychosis, Brief Reactive,Schizoaffective Disorder,Schizophreniform Disorders,Psychosis,Brief Reactive Psychoses,Brief Reactive Psychosis,Disorder, Psychotic,Disorder, Schizoaffective,Disorder, Schizophreniform,Disorders, Psychotic,Disorders, Schizoaffective,Disorders, Schizophreniform,Psychoses, Brief Reactive,Psychotic Disorder,Reactive Psychoses, Brief,Reactive Psychosis, Brief,Schizoaffective Disorders,Schizophreniform Disorder
D002746 Chlorpromazine The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup. Aminazine,Chlorazine,Chlordelazine,Chlorpromazine Hydrochloride,Contomin,Fenactil,Largactil,Propaphenin,Thorazine,Hydrochloride, Chlorpromazine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000166 Acridines Compounds that include the structure of acridine. Acridine

Related Publications

C P Chien, and M Sah, and G C Dubiel, and L Lu
Double blind study of an acridan derivative (SK & F 14336) versus chlorpromazine.
May 1968, Current therapeutic research, clinical and experimental,
C P Chien, and M Sah, and G C Dubiel, and L Lu
One-year trial of the antipsychotic acridan compound, SK&F 14336.
July 1969, Current therapeutic research, clinical and experimental,
C P Chien, and M Sah, and G C Dubiel, and L Lu
One-year trial of the antipsychotic acridan compound, SK AND F 14336.
June 1969, Behavioral neuropsychiatry,
C P Chien, and M Sah, and G C Dubiel, and L Lu
Controlled comparison of SK&F 14336 and chlorpromazine in newly admitted schizophrenics.
January 1969, The Journal of clinical pharmacology and the journal of new drugs,
C P Chien, and M Sah, and G C Dubiel, and L Lu
A controlled study of SK&F 14336 in acute schizophrenia.
January 1967, The Journal of clinical pharmacology and the journal of new drugs,
C P Chien, and M Sah, and G C Dubiel, and L Lu
A clinical study of a new nonphenothiazine tranquilizer (SK&F--14336).
April 1969, Current therapeutic research, clinical and experimental,
C P Chien, and M Sah, and G C Dubiel, and L Lu
Clinical trial of SK&F 14336 concentrate for chronic psychotics.
January 1969, Current therapeutic research, clinical and experimental,
C P Chien, and M Sah, and G C Dubiel, and L Lu
A comparison of an acridan derivative (Smith Kline and French 14336) and trifluoperazine in the treatment of chronic schizophrenia.
September 1969, The Medical journal of Australia,
C P Chien, and M Sah, and G C Dubiel, and L Lu
A double-blind study of SKF 14336 vs. trifluoperazine in schizophrenic patients.
October 1968, Current therapeutic research, clinical and experimental,
C P Chien, and M Sah, and G C Dubiel, and L Lu
Antiemetic effect of nonabine in cancer chemotherapy: a double blind study comparing nonabine and chlorpromazine.
January 1983, British medical journal (Clinical research ed.),
Copied contents to your clipboard!